In the present work we examine both the linear and nonlinear properties of two related PT-symmetric systems of the discrete nonlinear Schrödinger (dNLS) type.First, we examine the parameter range for which the finite PT-dNLS chains have real eigenvalues and PT-symmetric linear eigenstates. We develop a systematic way of analyzing the nonlinear stationary states with the implicit function theorem at an analogue of the anti-continuum limit for the dNLS equation.Secondly, we consider the case when a finite PT-dNLS chain is embedded as a defect in the infinite dNLS lattice. We show that the stability intervals of the infinite PT-dNLS lattice are wider than in the case of a finite PT-dNLS chain. We also prove existence of localized stationary states (discrete solitons) in the analogue of the anti-continuum limit for the dNLS equation.Numerical computations illustrate the existence of nonlinear stationary states, as well as the stability and saddle-center bifurcations of discrete solitons.
We consider nonlinear dynamics in a finite parity-time-symmetric chain of the discrete nonlinear Schrödinger (dNLS) type. We work in the range of the gain and loss coefficient when the zero equilibrium state is neutrally stable. We prove that the solutions of the dNLS equation do not blow up in a finite time and the trajectories starting with small initial data remain bounded for all times. Nevertheless, for arbitrary values of the gain and loss parameter, there exist trajectories starting with large initial data that grow exponentially fast for larger times with a rate that is rigorously identified. Numerical computations illustrate these analytical results for dimers and quadrimers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.